Controlant’s real-time visibility platform and control tower are already transforming pharmaceutical product distribution by meticulously tracking shipments from origin sites to distribution hubs.
The results? More than 99% successful pharma product delivery.
Now, the same methodology is being implemented by leading pharma companies in the clinical trial space.
Variables including location and temperature are monitored to provide total visibility, enabling comprehensive oversight and seamless planning at the click of a button.
Furthermore, captured information is then processed to provide historic, live, and predictive analytics data; the ability to set rules that trigger automated responses based on changes in this data keeps trials running smoothly, even when conducted remotely.
You can only act on data you trust.
Creating a system based on validated real- time data to enable well-informed, rapid decisions right across the supply chain, gives companies the reassurance they need.
We know from many discussions with supply chain leaders that our solutions help them operate supply chains much more eficiently, reduce waste, create value, and optimize the clinical trials process.
A lot of the time they see a ten-fold ROI – on solutions they initially didn’t even know they needed.
But to transform their pharma supply chains, and create value in doing so, they recognized that what we offer is an entirely different way to leverage technology.
“Once you have the information you need for a particular process, you can start looking at what else you can use it for,” explains Ada Pálmadóttir, VP of Business Development at Controlant.
“Our customers are discovering areas where they can benefit from connecting and combining information within our system, making more automation possible too.”
Talk to our clinical trial supply chain experts about the opportunity that is available now. We are experienced strategic advisors for the pharma cold chain – our door is open, our solutions are on the shelf, and can be tailored to your needs.
Read more on
controlant.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41
